patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Stem-cell stocks gain on sentiment for ban removal

Stem-cell stocks gain on sentiment for ban removal

posted on Feb 18, 2009 12:15PM

Tuesday February 17, 2:20 pm ET

http://biz.yahoo.com/ap/090217/secto...



Hopefully, soon we'll rocket... okie, still loooking for general trials time-frame.



e

Share
New Message
Please login to post a reply